Skip Nav Destination
1-6 of 6
Juan Ding, Xiao Ma, Liping Han, Xianlan Zhao, Ang Li, Qi Xin, Weining Lian, Zhen Li, Hongyan Ren, Zhigang Ren
Biosci Rep (2021) 41 (4): BSR20210362.
Published: 30 April 2021
... infants (NJIs) and identified gut microbial alterations in neonatal jaundice pre- and post-treatment. We prospectively collected 232 fecal samples from 51 infants at five time points (0, 1, 3, 6, and 12 months). Finally, 114 samples from 6 NJIs and 19 non-NJI completed MiSeq sequencing and analysis. We...
Includes: Supplementary data
Biosci Rep (2021) 41 (4): BSR-20140124_EOC.
Published: 19 April 2021
... © 2021 The Author(s). 2021 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . NUF2 pancreatic cancer RNA interface tumourigenesis treatment...
Biosci Rep (2020) 40 (9): BSR20192095.
Published: 16 September 2020
... with normal cartilage tissues, accompanied by up-regulation of EIF4G2 expression. An inverse correlation was found between EIF4G2 and miR-197 expressions in OA cartilage tissues. Treatment with miR-197 mimics promoted the growth and migration abilities of chondrocytes, while miR-197 inhibitors induced...
Biosci Rep (2020) 40 (2): BSR20191927.
Published: 20 February 2020
..., it is still incurable for some patients who have no or a weak response to traditional drugs, such as non-steroidal anti-inflammatory agents, glucocorticoids and immunosuppressive agents. This is called refractory reactive arthritis. Currently, there is insufficient evidences for the treatment of refractory...
Biosci Rep (2015) 35 (1): e00170.
Published: 14 January 2015
...-mediated knockdown against NUF2 may be a promising therapeutic method for the treatment of pancreatic cancer. Table 1 Relationship of NUF2 expression and clinicopathological parameters in PDAC patients ( n =128) P values were determined using a Pearson χ 2 test. NUF2 immunostaining...
Biosci Rep (2007) 27 (1-3): 139–150.
Published: 13 June 2007
... the complexities of mitochondrial genetics, there are no available cures for mtDNA disorders. In this review, we consider experimental, genetic-based strategies that have been or are being explored towards developing treatments, focussing on two specific areas which we are actively pursuing—assessing the benefit...